Cyclooxygenase-2 gene and epithelial ovarian carcinoma risk

被引:0
作者
Bedia Agachan Cakmakoglu
Rukset Attar
Ozlem Timirci Kahraman
Altay Burak Dalan
Ahmet Cem Iyibozkurt
Ates Karateke
Erkut Attar
机构
[1] Istanbul University,Department of Molecular Medicine, Institute for Experimental Medicine Research
[2] Yeditepe University Hospital,Department of Obstetrics and Gynecology
[3] Istanbul University,Department of Obstetrics and Gynecology, Istanbul Medical School
[4] Zeynep Kamil Research and Training Hospital,undefined
来源
Molecular Biology Reports | 2011年 / 38卷
关键词
Cox-2; Epithelial ovarian carcinoma; Polymorphism;
D O I
暂无
中图分类号
学科分类号
摘要
In this study, we aimed to investigate a possible association of the COX-2 polymorphisms (−765G→C and −1195A→G) and with the risk of developing epithelial ovarian carcinoma (EOC). COX-2 gene polymorphisms was investigated in 111 healthy women and 57 patients with EOC. Individuals who had −765 CG, −1195 AA genotype, and −765 C allele had increased risk for ovarian carcinoma (P < 0.01) and individuals with −765 GG, −1195 AG genotypes and −1195 G allele seem to be protected from ovarian carcinoma (P < 0.01). Haplotype analysis confirmed the association of COX-2 gene variants with ovarian carcinoma and revealed that the frequencies of −765C: −1195A haplotype frequencies was significantly higher in patients as compared with those of controls (P = 0.048). We state that there appears to be a modulating role for the COX-2 −1195A→G and −765G→C polymorphisms in the development of EOC. To the best of our knowledge, this is the first study to show such an association.
引用
收藏
页码:3481 / 3486
页数:5
相关论文
共 203 条
[1]  
Gerd HC(2008)Survival of ovarian cancer patients in Denmark: excess mortality risk analysis of fiveyear relative survival in the period 1978–2002 Acta Obstet Gynecol Scand 87 1353-1360
[2]  
Rikke C(2004)Cancer of the ovary N Engl J Med 351 2519-2529
[3]  
Gerda E(1973)Detection and isolation of an endoperoxide intermediate in prostaglandin biosynthesis Proc Natl Acad Sci USA 70 899-903
[4]  
Krüger KS(1998)Cyclooxygenase in biology and disease FASEB J 12 1063-1073
[5]  
Cannistra SA(2009)COX-2 polymorphisms −765G→C and −1195A→G and colorectal cancer risk World J Gastroenterol 15 4561-4565
[6]  
Hamberg M(1994)Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas Gastroenterology 107 1183-1188
[7]  
Samuelsson B(1998)Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer J Natl Cancer Inst 90 455-460
[8]  
Dubois RN(1998)Expression of cyclooxygenase-2 in human lung carcinoma Cancer Res 58 4997-5001
[9]  
Abramson SB(1999)Cyclooxygenase-2 expression in human esophageal carcinoma Cancer Res 59 198-204
[10]  
Crofford L(1999)Cyclooxygenase-2 expression in hepatocellular carcinoma Hepatogastroenterology 46 407-412